Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 32
Filter
1.
Biochem Biophys Res Commun ; 731: 150370, 2024 Jul 06.
Article in English | MEDLINE | ID: mdl-39047619

ABSTRACT

Single-molecule techniques are highly sensitive tools that can reveal reaction intermediates often obscured in experiments involving large ensembles of molecules. Therefore, they provide unprecedented information on the mechanisms that control biomolecular reactions. Currently, one of the most significant single-molecule assays is Magnetic Tweezers (MT), which probes enzymatic reactions at high spatio-temporal resolutions on tens, if not hundreds, of molecules simultaneously. For high-resolution MT experiments, a short double-stranded DNA molecule (less than 2000 base pairs) is typically attached between a micron-sized superparamagnetic bead and a surface. The fabrication of such a substrate is key for successful single-molecule assays, and several papers have discussed the possibility of improving the fabrication of short DNA constructs. However, reported yields are usually low and require additional time-consuming purification steps (e.g., gel purification). In this paper, we propose the use of a Golden Gate Assembly assay that allows for the production of DNA constructs within minutes (starting from PCR products). We discuss how relevant parameters may affect the yield and offer single-molecule experimentalists a simple yet robust approach to fabricate DNA constructs.

2.
J Biol Chem ; 294(33): 12483-12494, 2019 08 16.
Article in English | MEDLINE | ID: mdl-31248982

ABSTRACT

Protein tyrosine phosphatase, nonreceptor type 2 (PTPN2) is mainly expressed in hematopoietic cells, where it negatively regulates growth factor and cytokine signaling. PTPN2 is an important regulator of hematopoiesis and immune/inflammatory responses, as evidenced by loss-of-function mutations of PTPN2 in leukemia and lymphoma and knockout mice studies. Benzene is an environmental chemical that causes hematological malignancies, and its hematotoxicity arises from its bioactivation in the bone marrow to electrophilic metabolites, notably 1,4-benzoquinone, a major hematotoxic benzene metabolite. Although the molecular bases for benzene-induced leukemia are not well-understood, it has been suggested that benzene metabolites alter topoisomerases II function and thereby significantly contribute to leukemogenesis. However, several studies indicate that benzene and its hematotoxic metabolites may also promote the leukemogenic process by reacting with other targets and pathways. Interestingly, alterations of cell-signaling pathways, such as Janus kinase (JAK)/signal transducer and activator of transcription (STAT), have been proposed to contribute to benzene-induced malignant blood diseases. We show here that 1,4-benzoquinone directly impairs PTPN2 activity. Mechanistic and kinetic experiments with purified human PTPN2 indicated that this impairment results from the irreversible formation (kinact = 645 m-1·s-1) of a covalent 1,4-benzoquinone adduct at the catalytic cysteine residue of the enzyme. Accordingly, cell experiments revealed that 1,4-benzoquinone exposure irreversibly inhibits cellular PTPN2 and concomitantly increases tyrosine phosphorylation of STAT1 and expression of STAT1-regulated genes. Our results provide molecular and cellular evidence that 1,4-benzoquinone covalently modifies key signaling enzymes, implicating it in benzene-induced malignant blood diseases.


Subject(s)
Benzene , Benzoquinones/metabolism , Leukemia , Neoplasm Proteins , Protein Tyrosine Phosphatase, Non-Receptor Type 2 , STAT1 Transcription Factor , Signal Transduction/drug effects , Benzene/pharmacokinetics , Benzene/pharmacology , HEK293 Cells , Humans , Jurkat Cells , Leukemia/genetics , Leukemia/metabolism , Leukemia/pathology , Neoplasm Proteins/antagonists & inhibitors , Neoplasm Proteins/genetics , Neoplasm Proteins/metabolism , Protein Tyrosine Phosphatase, Non-Receptor Type 2/antagonists & inhibitors , Protein Tyrosine Phosphatase, Non-Receptor Type 2/genetics , Protein Tyrosine Phosphatase, Non-Receptor Type 2/metabolism , STAT1 Transcription Factor/genetics , STAT1 Transcription Factor/metabolism , Signal Transduction/genetics
3.
Mol Pharmacol ; 96(2): 297-306, 2019 08.
Article in English | MEDLINE | ID: mdl-31221825

ABSTRACT

Etoposide is a widely prescribed anticancer drug that is, however, associated with an increased risk of secondary leukemia. Although the molecular basis underlying the development of these leukemias remains poorly understood, increasing evidence implicates the interaction of etoposide metabolites [i.e., etoposide quinone (EQ)] with topoisomerase II enzymes. However, effects of etoposide quinone on other cellular targets could also be at play. We investigated whether T-cell protein tyrosine phosphatase (TCPTP), a protein tyrosine phosphatase that plays a key role in normal and malignant hematopoiesis through regulation of Janus kinase/signal transducer and activator of transcription signaling, could be a target of EQ. We report here that EQ is an irreversible inhibitor of TCPTP phosphatase (IC50 = ∼7 µM, second-order rate inhibition constant of ∼810 M-1⋅min-1). No inhibition was observed with the parent drug. The inhibition by EQ was found to be due to the formation of a covalent adduct at the catalytic cysteine residue in the active site of TCPTP. Exposure of human hematopoietic cells (HL60 and Jurkat) to EQ led to inhibition of endogenous TCPTP and concomitant increase in STAT1 tyrosine phosphorylation. Our results suggest that in addition to alteration of topoisomerase II functions, EQ could also contribute to etoposide-dependent leukemogenesis through impairment of key hematopoietic signaling enzymes, such as TCPTP.


Subject(s)
Etoposide/chemistry , Protein Tyrosine Phosphatase, Non-Receptor Type 2/chemistry , Protein Tyrosine Phosphatase, Non-Receptor Type 2/metabolism , Quinones/pharmacology , Binding Sites , Catalytic Domain , Cysteine/metabolism , Down-Regulation , Gene Expression Regulation/drug effects , HL-60 Cells , Humans , Jurkat Cells , Phosphorylation/drug effects , Quinones/chemistry , STAT1 Transcription Factor/metabolism
4.
Mol Pharmacol ; 92(3): 358-365, 2017 09.
Article in English | MEDLINE | ID: mdl-28674152

ABSTRACT

Thiram (tetramethylthiuram disulfide) is a representative dithiocarbamate (DTC) pesticide used in both the field and as a seed protectant. The widespread use of Thiram and other DTC pesticides has raised concerns for health, because these compounds can exert neuropathic, endocrine disruptive, and carcinogenic effects. These toxic effects are thought to rely, at least in part, on the reaction of Thiram (and certain of its metabolites) with cellular protein thiols with subsequent loss of protein function. So far, a limited number of molecular targets of Thiram have been reported, including few enzymes such as dopamine ß-hydroxylase, 11ß-hydroxysteroid dehydrogenase, and brain glycogen phosphorylase. We provide evidence that Thiram is an inhibitor (KI = 23 µM; kinact = 0.085 second-1; kinact/KI = 3691 M-1⋅s-1) of human arylamine N-acetyltransferase 1 (NAT1), a phase II xenobiotic-metabolizing enzyme that plays a key role in the biotransformation of aromatic amine xenobiotics. Thiram was found to act as an irreversible inhibitor through the modification of NAT1 catalytic cysteine residue as also reported for other enzymes targeted by this pesticide. We also showed using purified NAT1 and human keratinocytes that Thiram impaired the N-acetylation of 3,4-dichloroaniline (3,4-DCA), a major toxic metabolite of aromatic amine pesticides (such as Diuron or Propanil). As coexposure to different classes of pesticides is common, our data suggest that pharmacokinetic drug-drug interactions between DTC pesticides such as Thiram and aromatic amine pesticides may occur through alteration of NAT1 enzymes functions.


Subject(s)
Arylamine N-Acetyltransferase/antagonists & inhibitors , Fungicides, Industrial/pharmacology , Isoenzymes/antagonists & inhibitors , Thiram/pharmacology , Acetylation , Aniline Compounds/metabolism , Cells, Cultured , Dithiothreitol/pharmacology , Humans
5.
Arch Toxicol ; 89(12): 2403-12, 2015 Dec.
Article in English | MEDLINE | ID: mdl-25224404

ABSTRACT

Aromatic amines (AAs) are an important class of chemicals which account for 12 % of known carcinogens. The biological effects of AAs depend mainly on their biotransformation into reactive metabolites or into N-acetylated metabolites which are generally considered as less toxic. Although the activation of the aryl hydrocarbon receptor (AhR) pathway by certain carcinogenic AAs has been reported, the effects of their N-acetylated metabolites on the AhR have not been addressed. Here, we investigated whether carcinogenic AAs and their N-acetylated metabolites may activate/modulate the AhR pathway in the absence and/or the presence of a bona fide AhR ligand (benzo[a]pyrene/B(a)P]. In agreement with previous studies, we found that certain AAs activated the AhR in human liver and lung cells as assessed by an increase in cytochrome P450 1A1 (CYP1A1) expression and activity. Altogether, we report for the first time that these properties can be modulated by the N-acetylation status of the AA. Whereas 2-naphthylamine significantly activated the AhR and induced CYP1A1 expression, its N-acetylated metabolite was less efficient. In contrast, the N-acetylated metabolite of 2-aminofluorene was able to significantly activate AhR, whereas the parent AA, 2-aminofluorene, did not. In the presence of B(a)P, activation of AhR or antagonist effects were observed depending on the AA or its N-acetylated metabolite. Activation and/or modulation of the AhR pathway by AAs and their N-acetylated metabolites may represent a novel mechanism contributing to the toxicological effects of AAs. More broadly, our data suggest biological interactions between AAs and other classes of xenobiotics through the AhR pathway.


Subject(s)
Carcinogens/toxicity , Cytochrome P-450 CYP1A1/genetics , Gene Expression Regulation, Enzymologic/drug effects , Receptors, Aryl Hydrocarbon/drug effects , 2-Naphthylamine/administration & dosage , 2-Naphthylamine/metabolism , 2-Naphthylamine/toxicity , Acetylation , Aminobiphenyl Compounds/administration & dosage , Aminobiphenyl Compounds/metabolism , Aminobiphenyl Compounds/toxicity , Benzo(a)pyrene/administration & dosage , Benzo(a)pyrene/pharmacology , Carcinogens/metabolism , Cell Line , Cytochrome P-450 CYP1A1/metabolism , Fluorenes/administration & dosage , Fluorenes/metabolism , Fluorenes/toxicity , Hep G2 Cells , Humans , Liver/drug effects , Liver/metabolism , Lung/drug effects , Lung/metabolism , Receptors, Aryl Hydrocarbon/metabolism
6.
Acta Crystallogr D Biol Crystallogr ; 70(Pt 11): 3066-79, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25372695

ABSTRACT

Mycobacterium abscessus is the most pathogenic rapid-growing mycobacterium and is one of the most resistant organisms to chemotherapeutic agents. However, structural and functional studies of M. abscessus proteins that could modify/inactivate antibiotics remain nonexistent. Here, the structural and functional characterization of an arylamine N-acetyltransferase (NAT) from M. abscessus [(MYCAB)NAT1] are reported. This novel prokaryotic NAT displays significant N-acetyltransferase activity towards aromatic substrates, including antibiotics such as isoniazid and p-aminosalicylate. The enzyme is endogenously expressed and functional in both the rough and smooth M. abscessus morphotypes. The crystal structure of (MYCAB)NAT1 at 1.8 Šresolution reveals that it is more closely related to Nocardia farcinica NAT than to mycobacterial isoforms. In particular, structural and physicochemical differences from other mycobacterial NATs were found in the active site. Peculiarities of (MYCAB)NAT1 were further supported by kinetic and docking studies showing that the enzyme was poorly inhibited by the piperidinol inhibitor of mycobacterial NATs. This study describes the first structure of an antibiotic-modifying enzyme from M. abscessus and provides bases to better understand the substrate/inhibitor-binding specificities among mycobacterial NATs and to identify/optimize specific inhibitors. These data should also contribute to the understanding of the mechanisms that are responsible for the pathogenicity and extensive chemotherapeutic resistance of M. abscessus.


Subject(s)
Arylamine N-Acetyltransferase/chemistry , Mycobacterium/enzymology , Acetylation , Amino Acid Sequence , Arylamine N-Acetyltransferase/genetics , Arylamine N-Acetyltransferase/metabolism , Crystallography, X-Ray , Humans , Models, Molecular , Molecular Sequence Data , Mycobacterium/chemistry , Mycobacterium/genetics , Mycobacterium/metabolism , Mycobacterium Infections/microbiology , Phylogeny , Substrate Specificity
7.
Anal Biochem ; 449: 172-8, 2014 Mar 15.
Article in English | MEDLINE | ID: mdl-24374000

ABSTRACT

Down syndrome is the most common aneuploidy. It is caused by the presence of an extra copy of chromosome 21. Several studies indicate that aberrant expression of the kinase Dyrk1a (dual-specificity tyrosine phosphorylation-regulated kinase 1a) is implicated in Down syndrome, in particular in the onset of mental retardation. Moreover, elevated Dyrk1a activity may also be a risk factor for other neurodegenerative disorders such as Alzheimer's disease. Over the past years, Dyrk1a has appeared as a potential drug target. Availability of sensitive and quantitative enzyme assays is of prime importance to understand the role of Dyrk1a and to develop specific inhibitors. Here, we describe a new method to measure Dyrk1a activity based on the separation and quantification of specific fluorescent peptides (substrate and phosphorylated product) by high-performance liquid chromatography (HPLC). Kinetic and mechanistic analyses using well-known inhibitors of Dyrk1a confirmed the reliability of this approach. In addition, this assay was further validated using brain extracts of mice models expressing different copies of the Dyrk1a gene. Our results indicate that this novel Dyrk1a assay is simple, sensitive, and specific. It avoids the use of radioactivity-based approaches that, until now, have been widely employed to measure Dyrk1a activity.


Subject(s)
Chromatography, High Pressure Liquid/methods , Down Syndrome/enzymology , Enzyme Assays/methods , Protein Serine-Threonine Kinases/analysis , Protein-Tyrosine Kinases/analysis , Amino Acid Sequence , Animals , Brain/enzymology , Fluorescein/analysis , Fluorescence , Fluorescent Dyes/analysis , Humans , Mice , Molecular Sequence Data , Peptides/analysis , Peptides/metabolism , Phosphorylation , Protein Serine-Threonine Kinases/metabolism , Protein-Tyrosine Kinases/metabolism , Reproducibility of Results , Dyrk Kinases
8.
Methods Mol Biol ; 2741: 399-416, 2024.
Article in English | MEDLINE | ID: mdl-38217665

ABSTRACT

Useful structural information about the conformation of nucleic acids can be quickly acquired by circular and linear dichroism (CD/LD) spectroscopy. These techniques, rely on the differential absorption of polarised light and are indeed extremely sensitive to subtle changes in the structure of chiral biomolecules. Many CD analyses of DNA or DNA:protein complexes have been conducted with substantial data acquisitions. Conversely, CD RNA analysis are still scarce, despite the fact that RNA plays a wide cellular function. This chapter seeks to introduce the reader to the use of circular, linear dichroism and in particular the use of Synchrotron Radiation for such samples. The use of these techniques on small noncoding RNA (sRNA) will be exemplified by analyzing changes in base stacking and/or helical parameters for the understanding of sRNA structure and function, especially by translating the dynamics of RNA:RNA annealing but also to access RNA stability or RNA:RNA alignment. The effect of RNA remodeling proteins will also be addressed. These analyses are especially useful to decipher the mechanisms by which sRNA will adopt the proper conformation thanks to the action of proteins such as Hfq or ProQ in the regulation of the expression of their target mRNAs.


Subject(s)
RNA, Small Untranslated , RNA, Small Untranslated/genetics , Proteins/metabolism , RNA, Messenger/metabolism , DNA , Circular Dichroism , Host Factor 1 Protein
9.
Appl Environ Microbiol ; 79(15): 4719-26, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23728813

ABSTRACT

Trichoderma spp. are cosmopolitan soil fungi that are highly resistant to many toxic compounds. Here, we show that Trichoderma virens and T. reesei are tolerant to aromatic amines (AA), a major class of pollutants including the highly toxic pesticide residue 3,4-dichloroaniline (3,4-DCA). In a previous study, we provided proof-of-concept remediation experiments in which another soil fungus, Podospora anserina, detoxifies 3,4-DCA through its arylamine N-acetyltransferase (NAT), a xenobiotic-metabolizing enzyme that enables acetyl coenzyme A-dependent detoxification of AA. To assess whether the N-acetylation pathway enables AA tolerance in Trichoderma spp., we cloned and characterized NATs from T. virens and T. reesei. We characterized recombinant enzymes by determining their catalytic efficiencies toward several toxic AA. Through a complementary approach, we also demonstrate that both Trichoderma species efficiently metabolize 3,4-DCA. Finally, we provide evidence that NAT-independent transformation is solely (in T. virens) or mainly (in T. reesei) responsible for the observed removal of 3,4-DCA. We conclude that T. virens and, to a lesser extent, T. reesei likely utilize another, unidentified, metabolic pathway for the detoxification of AA aside from acetylation. This is the first molecular and functional characterization of AA biotransformation in Trichoderma spp. Given the potential of Trichoderma for cleanup of contaminated soils, these results reveal new possibilities in the fungal remediation of AA-contaminated soil.


Subject(s)
Amines/metabolism , Arylamine N-Acetyltransferase/metabolism , Fungal Proteins/metabolism , Soil Microbiology , Soil Pollutants/metabolism , Trichoderma/enzymology , Amino Acid Sequence , Arylamine N-Acetyltransferase/genetics , Biotransformation , Chromatography, High Pressure Liquid , Cloning, Molecular , Fungal Proteins/genetics , Molecular Sequence Data , Phylogeny , Polymerase Chain Reaction , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Sequence Alignment , Species Specificity , Trichoderma/genetics
10.
Drug Metab Dispos ; 41(7): 1300-5, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23633528

ABSTRACT

Acrolein is an electrophilic α,ß-unsaturated aldehyde of industrial, pharmaceutic, and toxicologic importance to which we are exposed in environmental, occupational, and therapeutic situations. Acrolein is known to exert different biologic effects through reactions with cellular macromolecules such as DNA, certain proteins, or glutathione. In many situations (such as in tobacco smoke or other fumes), exposure to acrolein occurs concomitantly with other compounds such as aromatic amine chemicals. Interestingly, it has been shown that acrolein could impact the cellular metabolism of aromatic xenobiotics through an indirect mechanism based on the transcriptional induction of phase II xenobiotic-metabolizing enzymes. Here we report a novel mechanism by which acrolein acts on the metabolism of aromatic foreign chemicals. We provide molecular, kinetic, and cellular evidence that acrolein can react directly and irreversibly with arylamine N-acetyltransferases, a major family of xenobiotic-metabolizing enzymes involved in the metabolization of aromatic amine chemicals. Formation of an acrolein adduct with a catalytic cysteine residue in the active site is responsible for the impairment of aromatic amine acetylation by the enzyme. This biochemical process may represent an additional mechanism by which acrolein impacts the metabolism and fate of aromatic amine drugs and pollutants.


Subject(s)
Acrolein/pharmacology , Arylamine N-Acetyltransferase/antagonists & inhibitors , Isoenzymes/antagonists & inhibitors , Xenobiotics/metabolism , Acetylation , Arylamine N-Acetyltransferase/metabolism , Cells, Cultured , Humans , Isoenzymes/metabolism , Kinetics
11.
Biochem J ; 445(2): 219-28, 2012 Jul 15.
Article in English | MEDLINE | ID: mdl-22545684

ABSTRACT

Legionella pneumophila is an opportunistic pathogen and the causative agent of Legionnaires' disease. Despite being exposed to many chemical compounds in its natural and man-made habitats (natural aquatic biotopes and man-made water systems), L. pneumophila is able to adapt and survive in these environments. The molecular mechanisms by which this bacterium detoxifies these chemicals remain poorly understood. In particular, the expression and functions of XMEs (xenobiotic-metabolizing enzymes) that could contribute to chemical detoxification in L. pneumophila have been poorly documented at the molecular and functional levels. In the present paper we report the identification and biochemical and functional characterization of a unique acetyltransferase that metabolizes aromatic amine chemicals in three characterized clinical strains of L. pneumophila (Paris, Lens and Philadelphia). Strain-specific sequence variations in this enzyme, an atypical member of the arylamine N-acetyltransferase family (EC 2.3.1.5), produce enzymatic variants with different structural and catalytic properties. Functional inactivation and complementation experiments showed that this acetyltransferase allows L. pneumophila to detoxify aromatic amine chemicals and grow in their presence. The present study provides a new enzymatic mechanism by which the opportunistic pathogen L. pneumophila biotransforms and detoxifies toxic aromatic chemicals. These data also emphasize the role of XMEs in the environmental adaptation of certain prokaryotes.


Subject(s)
Amines/metabolism , Arylamine N-Acetyltransferase/metabolism , Hydrocarbons, Aromatic/metabolism , Legionella pneumophila/enzymology , Arylamine N-Acetyltransferase/genetics , Blotting, Western , Circular Dichroism , Genetic Complementation Test , Genetic Variation , Inactivation, Metabolic , Legionella pneumophila/classification , Legionella pneumophila/genetics , Legionnaires' Disease/genetics , Legionnaires' Disease/microbiology , Phylogeny , Protein Folding , Recombinant Proteins/genetics , Recombinant Proteins/metabolism
12.
Methods Mol Biol ; 2538: 145-163, 2022.
Article in English | MEDLINE | ID: mdl-35951299

ABSTRACT

Amyloid inhibitors, such as the green tea compound epigallocatechin gallate EGCG, apomorphine or curlicide, have antibacterial properties. Conversely, antibiotics such as tetracycline derivatives or rifampicin also affect eukaryotic amyloids formation and may be used to treat neurodegenerative diseases. This opens the possibility for existing drugs to be repurposed in view of new therapy, targeting amyloid-like proteins from eukaryotes to prokaryotes and conversely. Here we present how to evaluate the effect of these amyloid-forming inhibitors on bacterial amyloid self-assemblies in vitro and on bacterial survival. The different approaches possible are presented.


Subject(s)
Amyloidosis , Catechin , Amyloid/metabolism , Amyloidogenic Proteins , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Bacteria/metabolism , Catechin/pharmacology , Humans
13.
BBA Adv ; 1: 100029, 2021.
Article in English | MEDLINE | ID: mdl-37082015

ABSTRACT

Nucleic acid amyloid proteins interactions have been observed in the past few years. These interactions often promote protein aggregation. Nevertheless, molecular basis and physiological consequences of these interactions are still poorly understood. Additionally, it is unknown whether the nucleic acid promotes the formation of self-assembly due to direct interactions or indirectly via sequences surrounding the amyloid region. Here we focus our attention on a bacterial amyloid, Hfq. This protein is a pleiotropic bacterial regulator that mediates many aspects of nucleic acids metabolism. The protein notably mediates mRNA stability and translation efficiency by using stress-related small non coding regulatory RNA. In addition, Hfq, thanks to its amyloid C-terminal region, binds and compacts DNA. A combination of experimental methodologies, including synchrotron radiation circular dichroism (SRCD), gel shift assay and infrared (FTIR) spectroscopy have been used to probe the interaction of Hfq C-terminal region with DNA. We clearly identify important amino acids in this region involved in DNA binding and polymerization properties. This allows to understand better how this bacterial amyloid interacts with DNA. Possible functional consequence to answer to stresses are discussed.

14.
Methods Mol Biol ; 2113: 263-280, 2020.
Article in English | MEDLINE | ID: mdl-32006320

ABSTRACT

Quantitative real-time PCR (qPCR) is a widely adopted technique used for scientific, clinical, diagnostic, or quality control purposes. One of the main applications of qPCR is gene expression analysis, although mutation detection, genotyping, DNA detection, and quantification (from pathogens or genetically modified organisms) are also investigated using this technique.Although nonspecific detection based on DNA-binding dyes (including SYBR Green I) offers versatility in qPCR assays, detection of the PCR product using fluorescent probes confers higher specificity and sensitivity to assays, justifying the use of fluorescent probes as a detection method.This chapter seeks to propose a procedure for the design of qPCR assays using fluorescent hydrolysis probe technology. Particular attention will be paid to explaining the steps necessary to ensure the specificity of the oligonucleotides used as primers or fluorescent probes.


Subject(s)
Fluorescent Dyes/chemistry , Oligonucleotide Probes/chemistry , RNA/analysis , Hydrolysis , Real-Time Polymerase Chain Reaction , Sensitivity and Specificity
15.
RNA Biol ; 6(4): 434-45, 2009.
Article in English | MEDLINE | ID: mdl-19535898

ABSTRACT

RNA molecules are important factors involved in different cellular processes and have a multitude of roles in the cell. These roles include serving as a temporary copy of genes used for protein synthesis or functions in translational machinery. Interestingly, RNA is so far the only biological molecule that serves both as a catalyst (like proteins) and as information storage (like DNA). However, in contrast to proteins well known to be able to self-associate in order to maintain the architecture of the cell, such RNA polymers are not prevalent in cells and are usually not favored by the flexibility of this molecule. In this work, we present evidence that such a polymer of a natural RNA, the DsrA RNA, exists in the bacterial cell. DsrA is a small noncoding RNA (87 nucleotides) of Escherichia coli that acts by base-pairing to mRNA in order to control the translation and the turnover of some mRNA, including rpoS mRNA, which encodes the sigma(s) RNA polymerase subunit involved in bacterial stress response. A putative model is proposed for the structure of this RNA polymer. Although the function of this polymerization is not known completely, we propose that the formation of such a structure could be involved in the regulation of DsrA ncRNA concentration in vivo or in a quality control mechanism used by the cell to eliminate misfolded RNAs.


Subject(s)
Escherichia coli/genetics , RNA, Untranslated/genetics , RNA, Untranslated/metabolism , Base Sequence , Biopolymers/genetics , Biopolymers/metabolism , Gene Expression Regulation, Bacterial , Molecular Sequence Data , Nucleic Acid Conformation , Nucleic Acid Denaturation , RNA, Small Untranslated , RNA, Untranslated/chemistry , RNA, Untranslated/ultrastructure , Ribonucleases/metabolism , Spectrophotometry, Ultraviolet , Spectroscopy, Fourier Transform Infrared
16.
FEBS Lett ; 593(8): 831-841, 2019 04.
Article in English | MEDLINE | ID: mdl-30883722

ABSTRACT

Recent studies have revealed a possible link between the activities of polymorphic arylamine N-acetyltransferases (NATs) and energy metabolism. We used a Nat1/Nat2 double knockout (KO) mouse model to demonstrate that ablation of the two Nat genes is associated with modest, intermittent alterations in respiratory exchange rate. Pyruvate tolerance tests show that double KO mice have attenuated hepatic gluconeogenesis when maintained on a high-fat/high-sucrose diet. Absence of the two Nat genes also leads to an increase in the hepatic concentration of coenzyme A in mice fed a high-fat/high-sucrose diet. Our results suggest a modest involvement of NAT in energy metabolism in mice, which is consistent with the absence of major phenotypic deregulation of energy metabolism in slow human acetylators.


Subject(s)
Arylamine N-Acetyltransferase/deficiency , Arylamine N-Acetyltransferase/genetics , Energy Metabolism/genetics , Animals , Coenzyme A/metabolism , Diet, High-Fat/adverse effects , Gene Knockout Techniques , Gluconeogenesis/genetics , Humans , Liver/metabolism , Mice
17.
Methods Mol Biol ; 1737: 231-248, 2018.
Article in English | MEDLINE | ID: mdl-29484597

ABSTRACT

Regulation of RNA turnover is of utmost importance for controlling the concentration of transcripts and consequently cellular protein levels. Among the processes controlling RNA decay, small noncoding regulatory RNAs (sRNAs) have recently emerged as major new players. In this chapter, we describe and discuss protocols that can be used to measure sRNA concentration in vivo and to assess sRNA decay rates in Gram-negative bacteria. Precisely, we focus our analyses on the Escherichia coli Gram-negative bacterium as a model. The information described in this chapter provides a guideline to help develop a protocol in order to assess these important parameters and to identify RNA-processing enzymes involved in sRNA degradation processes.


Subject(s)
Escherichia coli Proteins/metabolism , Escherichia coli/metabolism , RNA Processing, Post-Transcriptional , RNA Stability , RNA, Bacterial/metabolism , RNA, Small Untranslated/metabolism , Endoribonucleases/metabolism , Escherichia coli/genetics , Escherichia coli Proteins/genetics , Exoribonucleases/metabolism , Gene Expression Regulation, Bacterial , RNA, Bacterial/chemistry , RNA, Bacterial/genetics , RNA, Messenger/genetics , RNA, Messenger/metabolism , RNA, Small Untranslated/chemistry , RNA, Small Untranslated/genetics
18.
Sci Rep ; 8(1): 16792, 2018 11 14.
Article in English | MEDLINE | ID: mdl-30429520

ABSTRACT

Hfq is a pleiotropic regulator that mediates several aspects of bacterial RNA metabolism. The protein notably regulates translation efficiency and RNA decay in Gram-negative bacteria, usually via its interaction with small regulatory RNA. Besides these RNA-related functions, Hfq has also been described as one of the nucleoid associated proteins shaping the bacterial chromosome. Therefore, Hfq appears as a versatile nucleic acid-binding protein, which functions are probably even more numerous than those initially suggested. For instance, E. coli Hfq, and more precisely its C-terminal region (CTR), has been shown to induce DNA compaction into a condensed form. In this paper, we establish that DNA induces Hfq-CTR amyloidogenesis, resulting in a change of DNA local conformation. Furthermore, we clarify the effect of Hfq on DNA topology. Our results evidence that, even if the protein has a strong propensity to compact DNA thanks to its amyloid region, it does not affect overall DNA topology. We confirm however that hfq gene disruption influences plasmid supercoiling in vivo, indicating that the effect on DNA topology in former reports was indirect. Most likely, this effect is related to small regulatory sRNA-Hfq-based regulation of another protein that influences DNA supercoiling, possibly a nucleoid associated protein such as H-NS or Dps. Finally, we hypothesise that this indirect effect on DNA topology explains, at least partially, the previously reported effect of Hfq on plasmid replication efficiency.


Subject(s)
DNA/chemistry , Host Factor 1 Protein/physiology , Amyloidogenic Proteins/physiology , Bacterial Proteins , DNA-Binding Proteins/physiology , Escherichia coli Proteins/physiology , Nucleic Acid Conformation
19.
Methods Mol Biol ; 1297: 21-42, 2015.
Article in English | MEDLINE | ID: mdl-25895993

ABSTRACT

RNAs are flexible molecules involved in a multitude of roles in the cell. Specifically, noncoding RNAs (i.e., RNAs that do not encode a protein) have important functions in the regulation of biological processes such as RNA decay, translation, or protein translocation. In bacteria, most of those noncoding RNAs have been shown to be critical for posttranscriptional control through their binding to the untranslated regions of target mRNAs. Recent evidence shows that some of these noncoding RNAs have the propensity to self-assemble in prokaryotes. Although the function of this self-assembly is not known and may vary from one RNA to another, it offers new insights into riboregulation pathways. We present here the various approaches that can be used for the detection and analysis of bacterial small noncoding RNA self-assemblies.


Subject(s)
Bacteria/genetics , RNA, Bacterial/genetics , RNA, Small Untranslated/genetics , Gene Expression Regulation, Bacterial , Nucleic Acid Conformation , RNA Stability/genetics , RNA, Bacterial/isolation & purification , RNA, Messenger/genetics , RNA, Messenger/isolation & purification , RNA, Small Untranslated/isolation & purification
20.
Integr Biol (Camb) ; 7(1): 128-41, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25407044

ABSTRACT

The bacterial actin-homolog MreB is a key player in bacterial cell-wall biosynthesis and is required for the maintenance of the rod-like morphology of Escherichia coli. However, how MreB cellular levels are adjusted to growth conditions is poorly understood. Here, we show that DsrA, an E. coli small noncoding RNA (sRNA), is involved in the post-transcriptional regulation of mreB. DsrA is required for the downregulation of MreB cellular concentration during environmentally induced slow growth-rates, mainly growth at low temperature and during the stationary phase. DsrA interacts in an Hfq-dependent manner with the 5' region of mreB mRNA, which contains signals for translation initiation and thereby affects mreB translation and stability. Moreover, as DsrA is also involved in the regulation of two transcriptional regulators, σ(S) and the nucleoid associated protein H-NS, which negatively regulate mreB transcription, it also indirectly contributes to mreB transcriptional down-regulation. By using quantitative analyses, our results evidence the complexity of this regulation and the tangled interplay between transcriptional and post-transcriptional control. As transcription factors and sRNA-mediated post-transcriptional regulators use different timescales, we propose that the sRNA pathway helps to adapt to changes in temperature, but also indirectly mediates long-term regulation of MreB concentration. The tight regulation and fine-tuning of mreB gene expression in response to cellular stresses is discussed in regard to the effect of the MreB protein on cell elongation.


Subject(s)
Escherichia coli Proteins/genetics , Escherichia coli/cytology , Escherichia coli/genetics , Gene Expression Regulation, Bacterial/genetics , Models, Genetic , RNA, Small Untranslated/genetics , Actins/genetics , Cell Size , Computer Simulation , Stress, Physiological/genetics , Transcriptional Activation/genetics
SELECTION OF CITATIONS
SEARCH DETAIL